Skip to content

DEROTOX : DEgenerative ROtator cuff disease and botulinum TOXin

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-514074-40-00
Acronym
APHP210416
Enrollment
60
Registered
2024-07-22
Start date
2023-01-20
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative shoulder rotator cuff tendinopathy

Brief summary

Total SPADI score at 1 month.

Detailed description

Total SPADI score at 3 months, SPADI sub-scores at 3 months, Perceived overall improvement, by VAS at 1 and 3 months, Painkiller medication consumption over the 3 months of follow-up, Acceptability of treatment by VAS from 0 to 100 at 1 month and 3 months

Interventions

DRUGpoudre pour solution injectable
DRUGPlacebo of Xeomin 100 UI

Sponsors

Assistance Publique Hopitaux De Paris
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Total SPADI score at 1 month.

Secondary

MeasureTime frame
Total SPADI score at 3 months, SPADI sub-scores at 3 months, Perceived overall improvement, by VAS at 1 and 3 months, Painkiller medication consumption over the 3 months of follow-up, Acceptability of treatment by VAS from 0 to 100 at 1 month and 3 months

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026